decitabine

Leah SherwoodMyelodysplastic Syndromes | November 16, 2022
The researchers analyzed data from previously untreated adult patients with low- or intermediate-risk MDS.
Leah SherwoodMyelodysplastic Syndromes | February 2, 2023
A retrospective study showed that response rate and survival outcome are still modest for high-risk patients.
Leah SherwoodAcute Myeloid Leukemia | February 2, 2023
Of 23 patients, three achieved complete remission and 15 achieved complete remission with incomplete hematological recovery.
Advertisement
Advertisement
Advertisement
Advertisement